Regenerative medicine is often defined as the replacement, repair, or regeneration of cells, tissues, or organs in the body or a meaningful return of their function. This can be accomplished by a number of means but often involves the use of a patient’s own or donated tissue or cells.
Tissues used for regenerative medicine may be acellular (no longer contain living cells) or may contain living cells. These cells most likely act as part of the intended therapeutic function of these ‘live’ tissues.
BCA supports regenerative medicine companies by assisting them in procuring a compliant and reliable supply of just the right kind of tissue, derived from the right type of donor (or from the patients themselves), configured in the client-specified format, and delivered under client-specified conditions.
All tissues are provided unique per client specifications, protocols and compliance requirements. All tissue products can be provided as research-grade materials or, where required, in compliance with clinical-grade, cGMP regulatory standards. All BCA Blood Centers hold required FDA and state licenses and many hold various voluntary accreditations by AABB, FACT, and AATB, and several comply with relevant EU and ISO standards.
Of course, BCA is also able to arrange for cells to be isolated from procured tissues. For tissue-derived cell fractions, see our Cells section.
BCA also provides consulting services to clients needing assistance with respect to the acquisition of biological materials and/or their distribution and associated logistics.
Contact Gena Swisher to speak more about how BCA might help with tissue acquisition or provision.